Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Multiple, interconvertible states of human pluripotent stem cells.

Kerr CL, Cheng L.

Cell Stem Cell. 2010 Jun 4;6(6):497-9. doi: 10.1016/j.stem.2010.05.014. No abstract available. Erratum in: Cell Stem Cell. 2010 Aug 6;7(2):270.

2.

Lonely death dance of human pluripotent stem cells: ROCKing between metastable cell states.

Ohgushi M, Sasai Y.

Trends Cell Biol. 2011 May;21(5):274-82. doi: 10.1016/j.tcb.2011.02.004. Epub 2011 Mar 26. Review.

PMID:
21444207
3.

Human pluripotent stem cells for genetic disease modeling and drug screening.

Gauthier M, Maury Y, Peschanski M, Martinat C.

Regen Med. 2011 Sep;6(5):607-22. doi: 10.2217/rme.11.46. Review.

PMID:
21916596
4.

Dynamic equilibrium of heterogeneous and interconvertible multipotent hematopoietic cell subsets.

Weston W, Zayas J, Perez R, George J, Jurecic R.

Sci Rep. 2014 Jun 6;4:5199. doi: 10.1038/srep05199.

5.

Human pluripotent stem cells for disease modelling and drug screening.

Maury Y, Gauthier M, Peschanski M, Martinat C.

Bioessays. 2012 Jan;34(1):61-71. doi: 10.1002/bies.201100071. Epub 2011 Oct 28. Review.

PMID:
22038777
6.

Genetically-modified human pluripotent stem cells: new hopes for the understanding and the treatment of neurological diseases?

Nedelec S, Onteniente B, Peschanski M, Martinat C.

Curr Gene Ther. 2013 Apr;13(2):111-9. Review.

PMID:
23444870
7.

MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states.

Neveu P, Kye MJ, Qi S, Buchholz DE, Clegg DO, Sahin M, Park IH, Kim KS, Daley GQ, Kornblum HI, Shraiman BI, Kosik KS.

Cell Stem Cell. 2010 Dec 3;7(6):671-81. doi: 10.1016/j.stem.2010.11.012.

8.

Comparative FAIRE-seq analysis reveals distinguishing features of the chromatin structure of ground state- and primed-pluripotent cells.

Murtha M, Strino F, Tokcaer-Keskin Z, Sumru Bayin N, Shalabi D, Xi X, Kluger Y, Dailey L.

Stem Cells. 2015 Feb;33(2):378-91. doi: 10.1002/stem.1871.

9.

A chemical probe that labels human pluripotent stem cells.

Hirata N, Nakagawa M, Fujibayashi Y, Yamauchi K, Murata A, Minami I, Tomioka M, Kondo T, Kuo TF, Endo H, Inoue H, Sato S, Ando S, Kawazoe Y, Aiba K, Nagata K, Kawase E, Chang YT, Suemori H, Eto K, Nakauchi H, Yamanaka S, Nakatsuji N, Ueda K, Uesugi M.

Cell Rep. 2014 Mar 27;6(6):1165-74. doi: 10.1016/j.celrep.2014.02.006. Epub 2014 Mar 6.

10.

Functionally defined substates within the human embryonic stem cell compartment.

Tonge PD, Shigeta M, Schroeder T, Andrews PW.

Stem Cell Res. 2011 Sep;7(2):145-53. doi: 10.1016/j.scr.2011.04.006. Epub 2011 May 11.

11.

A medium hyperglycosylated podocalyxin enables noninvasive and quantitative detection of tumorigenic human pluripotent stem cells.

Tateno H, Onuma Y, Ito Y, Hiemori K, Aiki Y, Shimizu M, Higuchi K, Fukuda M, Warashina M, Honda S, Asashima M, Hirabayashi J.

Sci Rep. 2014 Feb 12;4:4069. doi: 10.1038/srep04069.

12.

Pluripotent stem cells exhibiting similar characteristics can be isolated from human fetal bone marrow, heart, liver, muscle, lung, derma, kidney, and fat.

Fang B, Song Y, Zhao C, Shi M, Lin Q.

Front Med China. 2007 May;1(2):185-91. doi: 10.1007/s11684-007-0035-1. Epub 2007 Feb 1.

PMID:
24557674
13.

Culture of human pluripotent stem cells using completely defined conditions on a recombinant E-cadherin substratum.

Nagaoka M, Si-Tayeb K, Akaike T, Duncan SA.

BMC Dev Biol. 2010 Jun 2;10:60. doi: 10.1186/1471-213X-10-60.

14.

Heightened potency of human pluripotent stem cell lines created by transient BMP4 exposure.

Yang Y, Adachi K, Sheridan MA, Alexenko AP, Schust DJ, Schulz LC, Ezashi T, Roberts RM.

Proc Natl Acad Sci U S A. 2015 May 5;112(18):E2337-46. doi: 10.1073/pnas.1504778112. Epub 2015 Apr 13.

15.

Flow cytometric analysis of human pluripotent stem cells.

Ho MS, Fryga A, Laslett AL.

Methods Mol Biol. 2011;767:221-30. doi: 10.1007/978-1-61779-201-4_16.

PMID:
21822878
16.

[Expression patterns of germ line specific genes in mouse and human pluripotent stem cells are associated with regulation of ground and primed state of pluripotency].

Gordeev OF, Lifantseva NV, Khaĭdukov SV.

Ontogenez. 2011 Nov-Dec;42(6):403-24. Russian. Erratum in: Ontogenez. 2014 Mar-Apr;45(2):129.

PMID:
22288104
17.

Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine.

Lapillonne H, Kobari L, Mazurier C, Tropel P, Giarratana MC, Zanella-Cleon I, Kiger L, Wattenhofer-Donzé M, Puccio H, Hebert N, Francina A, Andreu G, Viville S, Douay L.

Haematologica. 2010 Oct;95(10):1651-9. doi: 10.3324/haematol.2010.023556. Epub 2010 May 21.

18.

Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells.

Ben-David U, Nudel N, Benvenisty N.

Nat Commun. 2013;4:1992. doi: 10.1038/ncomms2992.

PMID:
23778593
19.

Energy metabolism in human pluripotent stem cells and their differentiated counterparts.

Varum S, Rodrigues AS, Moura MB, Momcilovic O, Easley CA 4th, Ramalho-Santos J, Van Houten B, Schatten G.

PLoS One. 2011;6(6):e20914. doi: 10.1371/journal.pone.0020914. Epub 2011 Jun 17.

20.

rBC2LCN, a new probe for live cell imaging of human pluripotent stem cells.

Onuma Y, Tateno H, Hirabayashi J, Ito Y, Asashima M.

Biochem Biophys Res Commun. 2013 Feb 15;431(3):524-9. doi: 10.1016/j.bbrc.2013.01.025. Epub 2013 Jan 12.

Supplemental Content

Support Center